Phosphodiesterase 4 as a therapeutic target in Parkinson's disease recent advances.

Zhong J, Xu J, Xue J, Qiu Z, Chen B, Yu X, Lin Z

DOI: 10.1016/j.expneurol.2026.115680
Published: 2026 Jun
Container: Experimental neurology
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.expneurol.2026.115680,
  title = {Phosphodiesterase 4 as a therapeutic target in Parkinson's disease recent advances.},
  author = {Zhong J and Xu J and Xue J and Qiu Z and Chen B and Yu X and Lin Z},
  year = {2026},
  journal = {Experimental neurology},
  doi = {10.1016/j.expneurol.2026.115680},
  url = {https://doi.org/10.1016/j.expneurol.2026.115680}
}

RIS

TY  - JOUR
TI  - Phosphodiesterase 4 as a therapeutic target in Parkinson's disease recent advances.
AU  - Zhong J
AU  - Xu J
AU  - Xue J
AU  - Qiu Z
AU  - Chen B
AU  - Yu X
AU  - Lin Z
PY  - 2026
JO  - Experimental neurology
DO  - 10.1016/j.expneurol.2026.115680
UR  - https://doi.org/10.1016/j.expneurol.2026.115680
ER  -

APA

J, Z., J, X., J, X., Z, Q., B, C., X, Y., & Z, L. (2026). Phosphodiesterase 4 as a therapeutic target in Parkinson's disease recent advances.. Experimental neurology. https://doi.org/10.1016/j.expneurol.2026.115680

Source records

pubmed · retrieved 2026-09-27T13:21:07.651Z